202 related articles for article (PubMed ID: 24955371)
1. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.
Duyu M; Durmaz B; Gunduz C; Vergin C; Yilmaz Karapinar D; Aksoylar S; Kavakli K; Cetingul N; Irken G; Yaman Y; Ozkinay F; Cogulu O
Biomed Res Int; 2014; 2014():967585. PubMed ID: 24955371
[TBL] [Abstract][Full Text] [Related]
2. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia.
Shafik RE; Abd El Wahab N; Mokhtar MM; El Taweel MA; Ebeid E
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3429-3434. PubMed ID: 33247705
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
4. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
5. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
7. [microRNA expression in childhood acute granulocytic leukemia and its subtypes].
Luo XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang LD
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):831-5. PubMed ID: 22335948
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
9. Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
Mosakhani N; Missiry ME; Vakkila E; Knuutila S; Vakkila J
J Pediatr Hematol Oncol; 2017 Nov; 39(8):585-588. PubMed ID: 29068867
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Valiollahi E; Ribera JM; Genescà E; Behravan J
Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
14. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.
Mei Y; Gao C; Wang K; Cui L; Li W; Zhao X; Liu F; Wu M; Deng G; Ding W; Jia H; Li Z
Cancer Sci; 2014 Apr; 105(4):463-72. PubMed ID: 24720529
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.
Swellam M; El-Khazragy N
Tumour Biol; 2016 Aug; 37(8):10571-6. PubMed ID: 26857279
[TBL] [Abstract][Full Text] [Related]
17. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia.
Egyed B; Kutszegi N; Sági JC; Gézsi A; Rzepiel A; Visnovitz T; Lőrincz P; Müller J; Zombori M; Szalai C; Erdélyi DJ; Kovács GT; Semsei ÁF
J Transl Med; 2020 Jun; 18(1):250. PubMed ID: 32571344
[TBL] [Abstract][Full Text] [Related]
19. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia.
Shahid S; Shahid W; Shaheen J; Akhtar MW; Sadaf S
Sci Rep; 2021 Nov; 11(1):22783. PubMed ID: 34815474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]